Nicholas Siciliano

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

Orthovita, Inc. engages in the development and commercialization of synthetic biologically-active tissue engineering products for restoration of the human skeleton. The company was incorporated in 1992 and is headquartered in Malvern, PA.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

JPMorgan Chase & Co. (Investment Management) (JPM-IM) is the investment management division of JPMorgan Chase & Co. (NYSE: JPM), a multinational investment bank and financial services holding company headquartered in New York City. JPM-IM offers investment solutions to individuals, corporations, governments and institutions.

Cross Atlantic Capital Partners LLC (Cross Atlantic Capital) is a venture capital firm founded in 1999 by Donald Caldwell and Gerry McCrory. The firm is headquartered in Radnor, Pennsylvania with an additional offices in the United Kingdom and Israel.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

Acorn Performance Group, Inc. engages in the provision of profitability and cost management software solutions. It offers process modeling, data integration, calculation engine, and reporting into a solution for guiding a business. The firm serves the automotive, banking, chemical, consumer products, distribution, education, financial services, healthcare, information technology, insurance, manufacturing, retail, transportation and logistics, and utilities sectors. The company was founded by Steven R. Anderson and Jim Brigman on July 6, 2001 and is headquartered in Austin, TX.

Fujirebio Diagnostics AB develops and manufactures immunological reagents. It focuses on the development of monoclonal antibodies which fight against biochemical markers of diseases. The firm distributes products to the international biotech and diagnostic industries. The company is headquartered in Gothenburg, Sweden.

University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA.

Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania.

The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson.

Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009.

PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ.

Miroculus, Inc. operates as a biotechnology company specializing in microRNA-based diagnostics. It offers a non-invasive microRNA detection platform for molecular data gathering, analysis, and interpretation applications. The company was founded by Alejandro Tocigl Domeyko, Jorge Soto and Fay Christodoulou and is headquartered in San Francisco, CA.

Onkos Surgical, Inc. provides surgical oncology solutions. It delivers implants and instruments that meet the needs of musculoskeletal tumor patients. The company was founded by Patrick Treacy, Antony Koblish and Adele Oliva in 2015 and is headquartered in Parsippany, NJ.

CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.

Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts.

Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA.

Interius BioTherapeutics, Inc. is a biopharmaceutical company that targets cancer. The company was founded by Saar Gill and is headquartered in Philadelphia, PA.

Humboldt Capital LLC (Humboldt Capital) is a venture capital firm founded in 2020. The firm is headquartered in New York.

Phage Technologies SA develops bacteriophage treatments for controlling bacteria in breeding processes in the poultry, livestock, and aquaculture industry. The company is based in Macul, Chile. The Chilean company aims to reduce the use of antibiotics for disease control. The CEO of the company is Hans Pieringer.

Build Momentum, Inc. was founded in 2005 and is a company that helps organizations design, develop, and deploy innovative cleantech projects. The company is based in Sacramento, CA and has subsidiaries in the United States. The company's vision is to create a world where clean energy, water, and transportation are abundant, affordable, and available to all. The company has a team of experts who can take on any aspect of a cleantech project, from developing a blueprint to commercialization.

Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina.